Business Context and Reporting Period
Company: NanoViricides, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 1, 2011
Event: Entry into a Material Definitive Agreement for a securities offering.
Key Financial Metrics
- Transaction Type: Sale of Series B Convertible Preferred Stock.
- Investor: Seaside 88, LP.
- Initial Closing Proceeds: $2,500,000 (Gross).
- Shares Sold (Initial): 250,000 shares of Series B Preferred Stock.
- Purchase Price: $10.00 per share of Preferred Stock.
- Offering Expenses: Approximately $180,000 (Placement agent and attorneys' fees).
- Net Proceeds (Estimated): Approximately $2,320,000.
- Placement Fee: 6% of gross purchase price paid to Midtown Partners & Co., LLC.
- Conversion Price (Initial): $0.782 per share of Common Stock.
Material Changes and Transaction Structure
The Company entered into a Securities Purchase Agreement to sell up to 500,000 shares of Series B Convertible Preferred Stock. The transaction is structured in two closings:
- Initial Closing (Completed Nov 2, 2011): Seaside purchased 250,000 shares for $2,500,000.
- Subsequent Closing (Conditional): Seaside will purchase the remaining 250,000 shares for $2,500,000 fourteen weeks after the Initial Closing, subject to satisfaction of conditions precedent.
Conversion Mechanics: 40,000 shares of Preferred Stock automatically convert to Common Stock at the Initial Closing, Subsequent Closing, and every 14 days thereafter. The conversion price is based on a discount to the Volume Weighted Average Price (VWAP) of the Common Stock, with a floor price of $0.20.
Outlook, Risks, and Management Commentary
The filing contains forward-looking statements regarding the anticipated subsequent closings. Management highlights the following risks and contingencies:
- Closing Conditions: The subsequent closing is not guaranteed and depends on the Company satisfying specific conditions.
- Dilution: Substantial dilution to current stockholders is expected due to the purchase price discount offered to Seaside.
- Market Overhang: Potential market overhang may develop if Seaside resells the shares acquired under the Agreement.
- Regulatory Status: The offering is made pursuant to a shelf registration statement (Form S-3) declared effective on April 29, 2010.
Investor Verification Checklist
- Verify the exact terms of the "conditions precedent" required for the Subsequent Closing.
- Review the full Securities Purchase Agreement (Exhibit 10.1) for covenants and indemnification clauses.
- Assess the impact of the automatic conversion mechanism on future share count and dilution.
- Confirm the current trading volume and VWAP of the Common Stock to evaluate the conversion price floor risk.
- Check for any subsequent filings regarding the satisfaction of conditions for the second tranche of funding.